Dr. Vivek Subbiah
Claim this profileMD Anderson Cancer Center
Expert in Solid Tumors
Expert in Uterine Tumors
32 reported clinical trials
47 drugs studied
About Vivek Subbiah
Education:
- Obtained a medical degree from Sri Ramachandra Medical College and Research Institute, Chennai, India.
- Completed a combined residency in Internal Medicine and Pediatrics at Case Western Reserve University, MetroHealth, Cleveland, Ohio.
- Pursued fellowships in both adult and pediatric oncology at The University of Texas MD Anderson Cancer Center.
Experience:
- Served nearly 15 years at The University of Texas MD Anderson Cancer Center in various leadership roles, including Associate Professor and Executive Director of Medical Oncology Research.
- Principal investigator in over 100 phase I/II trials, significantly contributing to FDA and international approvals.
- Joined Sarah Cannon Research Institute in 2023 as Chief of Early-Phase Drug Development, leading the expansion of early-phase capabilities.
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
RET positive
2Uterine Tumors
Global LeaderStage IV
HER2 positive
Stage III
Affiliated Hospitals
Clinical Trials Vivek Subbiah is currently running
GSK5764227
for Advanced Cancer
The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of GSK5764227. The study will also see how the levels of GSK5764227 will change over time at different dose amounts when administered alone and in combination with other medicines like carboplatin, cisplatin, atezolizumab, pembrolizumab, durvalumab, bevacizumab, cetuximab.
Recruiting1 award Phase 12 criteria
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies
Recruiting1 award Phase 1 & 2
More about Vivek Subbiah
Clinical Trial Related3 years of experience running clinical trials · Led 32 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Vivek Subbiah has experience with
- Pembrolizumab
- Nivolumab
- Sapanisertib
- IO-108
- Cemiplimab
- Everolimus
Breakdown of trials Vivek Subbiah has run
Solid Tumors
Uterine Tumors
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Vivek Subbiah specialize in?
Is Vivek Subbiah currently recruiting for clinical trials?
Are there any treatments that Vivek Subbiah has studied deeply?
What is the best way to schedule an appointment with Vivek Subbiah?
What is the office address of Vivek Subbiah?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.